Microglial Immunoregulation by Apoptotic Cellular Membrane Mimetic Polymeric Particles

Yasuhiro Nakagawa1,2,3,4,5, Jeonggyu Lee4,5, Yihua Liu4

  • 1School of Materials and Chemical Technology, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.

ACS Macro Letters
|May 16, 2022
PubMed

Insights

Phosphatidylserine-exposing polymeric particles (PSPs) effectively polarize microglia from an inflammatory (Mi1) to an anti-inflammatory (Mi2) state. This suggests PSPs hold promise for novel anti-inflammatory therapies.

Area of Science:

  • Immunology
  • Biomaterials Science
  • Neuroinflammation

Background:

  • Phosphatidylserine (PtdSer) is a phospholipid exposed on apoptotic cells, known to modulate immune responses.
  • Microglia, the resident immune cells of the central nervous system, exist in different activation states, including inflammatory (Mi1) and anti-inflammatory (Mi2) phenotypes.
  • Targeting microglia polarization is a key strategy for developing anti-inflammatory therapies.

Purpose of the Study:

  • To investigate the microglia polarization effects of PtdSer-exposing polymeric particles (PSPs).
  • To evaluate the therapeutic potential of PSPs in modulating neuroinflammation.

Main Methods:

  • In vitro cell culture experiments using microglia.
  • In vivo animal models to assess therapeutic efficacy.
  • Analysis of microglia polarization markers (Mi1 and Mi2).
  • Investigation of the underlying molecular mechanisms, including peroxisome proliferator-activated receptor gamma (PPARγ) signaling.

Main Results:

  • PSPs successfully induced a shift in microglia polarization.
  • Upregulation of the anti-inflammatory Mi2 microglia phenotype was observed.
  • Suppression of the inflammatory Mi1 microglia phenotype was achieved.
  • PPARγ upregulation was identified as a key mechanism mediating PSP effects both in vitro and in vivo.

Conclusions:

  • PSPs effectively polarize microglia towards an anti-inflammatory phenotype.
  • The mechanism involves the upregulation of PPARγ.
  • PSPs demonstrate significant potential for developing novel anti-inflammatory therapies, particularly for neuroinflammatory conditions.